William J. Canestaro

Author

Also Known As

W Canestaro, W. Canestaro, W. J. Canestaro, W.J. Canestaro, William Canestaro, William J Canestaro, William J. Canestaro

Publications

576

Citations

H-Index

Concepts

All Affiliations

University of Washington CVS Health (United States)Brigham and Women's Hospital Harvard University

About

William J. Canestaro is an author at University of Washington specializing in public health, medicine, and reproductive health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	32
2	Public Health	2	2	32
3	Epidemiology	1	1	17
4	Genetic Medicine	1	1	17
5	Health Policy	1	1	15

William J. Canestaro

Publications

217

Citations

H-Index

Page 1

	Year	Citations
Cost-Effectiveness of Oral Anticoagulants for Treatment of Atrial Fibrillation William J. Canestaro, Amanda R. Patrick, Jerry Avorn, Circulation Cardiovascular Quality and Outcomes	2013	83
Clinical Evidence Supporting Pharmacogenomic Biomarker Testing Provided in US Food and Drug Administration Drug Labels Bo Wang, William J. Canestaro, Niteesh K. Choudhry JAMA Internal Medicine	2014	45
The cost-effectiveness of alectinib in anaplastic lymphoma kinase-positive (ALK+) advanced NSCLC previously treated with crizotinib JJ Carlson, William J. Canestaro, Arliene Ravelo, Journal of Medical Economics	2017	25
Use of a Blood Biomarker Test Improves Economic Utility in the Evaluation of Older Patients Presenting with Cognitive Impairment William J. Canestaro, Randall J. Bateman, David M. Holtzman, Population Health Management	2024	18
Statin Pharmacogenomics: Opportunities to Improve Patient Outcomes and Healthcare Costs with Genetic Testing William J. Canestaro, David G. Brooks, Donald Chaplin, Journal of Personalized Medicine Genetic TestingStatin PharmacogenomicsGenetic EpidemiologyPharmacotherapyPreventive Cardiology	2012	17
Implications of employer coverage of contraception: Cost‐effectiveness analysis of contraception coverage under an employer mandate William J. Canestaro, Elisabeth Vodicka, Don Downing, Contraception Health Insurance ReformEmployer MandateContraceptionContraceptive UseHealth Policy	2016	15
Impact of <i>CYP2C19</i> Genetic Testing on Provider Prescribing Patterns for Antiplatelet Therapy After Acute Coronary Syndromes and Percutaneous Coronary Intervention Nihar R. Desai, William J. Canestaro, Pavlo Kyrychenko, Circulation Cardiovascular Quality and Outcomes	2013	14

Page 1